Please review our updated Privacy & Cookies Notice.
SEATTLE, January 26, 2020 – The Bill & Melinda Gates Foundation today announced that it is immediately committing $10 million in emergency funds and corresponding technical support to help frontline responders in China and Africa accelerate their efforts to contain the global spread of 2019-nCoV.
The foundation is committing $5 million to the 2019-nCoV response in China and is already working with a range of Chinese public and private sector partners to accelerate national and international cooperation in areas of critical need, including efforts to identify and confirm cases, safely isolate and care for patients and accelerate the development of treatments and vaccines.
Partners include the National Health Commission and Chinese Center for Disease Control and Prevention, the National Natural Science Foundation of China and various research institutes affiliated with the Chinese Academy of Sciences, Xiamen University and Sinopharm China National Biotec Group.
The foundation is also immediately committing $5 million to assist the Africa Centers for Disease Control and Prevention in scaling up public health measures against 2019-nCoV among African Union member states. These measures will include technical support to implement the screening and treatment of suspected cases, laboratory confirmation of 2019-nCoV diagnoses and the safe isolation and care of identified cases.
About the Bill & Melinda Gates Foundation
Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people’s health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Sue Desmond-Hellmann and Co-chair William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren Buffett.